Licensing deal threatens cheap pharmaceuticals

Stella is four, and lives on HIV drugs. Next week, the EU may cut her supply.

First published in The Independent newspaper: MSF, which treats hundreds of thousands of patients in the developing world, is campaigning against the changes and demanding talks with the EU. "It is a case where profits are coming before lives," said Dr Unni Karunakara, the MSF president. "We are talking about real lives. They may be hidden away in remote areas but they are real. There are millions of lives depending on these cheap drugs, so we're saying hands off our medicines."

Read the complete article on The Independent website here.